Drug-labels.com

Campral: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
333 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Campral

ABOUT THIS MEDICATION

What the medication is used for:

CAMPRAL® is used to help alcohol dependent people keep from drinking alcohol. It should be used as part of a complete treatment program that includes counselling. Before beginning this medication, you should no longer be drinking alcohol. CAMPRAL® has not been shown to be effective if you are still drinking when you start taking it.

What it does:

CAMPRAL® is believed to work by restoring the natural balance of chemicals in the brain.

When it should not be used:

  • If you are sensitive (allergic) to CAMPRAL®, or any

    component of this medication (see, "What the important nonmedicinal ingredients are” section).

  • If you suffer from severe kidney problems.
  • If you are breast-feeding.

What the medicinal ingredient is:

Acamprosate calcium

What the important nonmedicinal ingredients are:

anionic copolymer of methacrylic acid and acrylic acid ethyl ester, colloidal anhydrous silica, crospovidone, magnesium silicate, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium starch glycolate and talc.

What dosage forms it comes in:

Each CAMPRAL® delayed-release tablet 333 mg is available as an enteric-coated, white, round-shaped tablet with “333” on one side. Tablets are supplied in blisters of 84 tablets.

WARNINGS AND PRECAUTIONS

If you develop any new or worsening mental health symptoms such as depression or thoughts of suicide while taking CAMPRAL® you should talk to your doctor or pharmacist immediately.

The use of CAMPRAL® does not eliminate or reduce the symptoms of alcohol withdrawal (the symptoms people experience when they stop drinking alcohol abruptly when they are dependent

on alcohol).

CAMPRAL® therapy should be used as a part of a treatment program that includes counselling and support.

CAMPRAL® therapy should be continued as directed, even in the event of relapse (renewed drinking of alcohol) and any renewed drinking should be discussed with your doctor.

BEFORE you use CAMPRAL® talk to your doctor or pharmacist if:

  • You are pregnant or likely to become pregnant.
  • Campral could be used during pregnancy if you can not abstain from alcohol without being treated with Campral. Campral does not prevent the harmful effect on fetus of alcohol intake.

Although in controlled studies CAMPRAL® has not been shown to impair coordination, certain drugs (e.g. sedatives, antidepressants) may impair judgment, thinking, or motor skills. Take precaution when operating hazardous machinery, including automobiles, until you are reasonably certain that CAMPRAL® therapy does not affect your ability to participate in such activities.

INTERACTIONS WITH THIS MEDICATION

CAMPRAL® has not been shown to interact significantly with other medications. If you are currently taking a medication, whether on prescription or otherwise, inform you doctor or pharmacist.

PROPER USE OF THIS MEDICATION

Usual dose:

The recommended dose of CAMPRAL® is two 333 mg tablets taken three times daily. CAMPRAL® should be swallowed whole, not crushed or chewed or split, and may be taken with or without food.

Treatment in patients with moderate kidney disease requires a dose reduction (one 333 mg tablet taken three times daily).

Never take more than the prescribed dose.

Lower dose may be prescribed temporarily for tolerability reasons.

Overdose:

Seek emergency medical attention. Symptoms of overdose may include diarrhea.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Page 22 of 22 Missed Dose:

If you missed a dose, skipped the missed dose and resume your

usual dosing schedule. Do not double the dose to catch up.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The side effects most often seen are gastrointestinal in nature, such as diarrhea, abdominal pain, gas and nausea. If you experience any of these effects, continue taking CAMPRAL® and talk to your doctor.

Other less common side effects may include:

  • Rash, itching
  • Weight gain/loss,
  • Change in sexual desire or ability

Check with you doctor or pharmacists if you experience any unexpected effects, or are concerned by the above side effects

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Common

Rash or itching

Thoughts or acts of self

harm (suicide)

√√
Uncommon

Allergic

reaction (Rash or itching,

swelling,

severe

dizziness,

trouble

breathing)

Joint pain

√

√

This is not a complete list of side effects. For any unexpected effects while taking CAMPRAL®, contact your doctor or pharmacist.

HOW TO STORE IT

Store at room temperature (15-30°C).

Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at: www.healthcanada.gc/ca/medeffectt
  • Call toll-free at: 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701D

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada web site at

www.healthcanada.gc.ca/medeffect

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found at:

http:// www.mylan.ca

or by contacting the sponsor, Mylan Pharmaceuticals ULC, at: 1-800-575-1379

Last revised: September 8, 2011

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02293269

Revision date stated in the text: September 8, 2011

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Campral

Rx or OTC
Prescription (Rx)?
DIN 02293269
Schedule(s) PRESCRIPTION
Active ingredient(s) Acamprosate calcium 333 MG
Dosage form(s) Tablet (Delayed-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07B Drugs used in addictive disorders
        1. N07BB Drugs used in alcohol dependence
          1. N07BB03 Acamprosate
Company MYLAN PHARMACEUTICALS ULC
Current status Marketed
Current status date May 28, 2010

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.